Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Inventory (2016 - 2025)

Prestige Consumer Healthcare has reported Inventory over the past 15 years, most recently at $163.6 million for Q4 2025.

  • Quarterly results put Inventory at $163.6 million for Q4 2025, up 7.97% from a year ago — trailing twelve months through Dec 2025 was $163.6 million (up 7.97% YoY), and the annual figure for FY2025 was $147.7 million, up 6.48%.
  • Inventory for Q4 2025 was $163.6 million at Prestige Consumer Healthcare, up from $159.0 million in the prior quarter.
  • Over the last five years, Inventory for PBH hit a ceiling of $169.8 million in Q2 2023 and a floor of $105.5 million in Q2 2021.
  • Median Inventory over the past 5 years was $150.1 million (2023), compared with a mean of $142.6 million.
  • Biggest five-year swings in Inventory: skyrocketed 49.16% in 2022 and later dropped 14.44% in 2024.
  • Prestige Consumer Healthcare's Inventory stood at $106.3 million in 2021, then skyrocketed by 49.16% to $158.5 million in 2022, then fell by 6.24% to $148.6 million in 2023, then rose by 1.94% to $151.5 million in 2024, then grew by 7.97% to $163.6 million in 2025.
  • The last three reported values for Inventory were $163.6 million (Q4 2025), $159.0 million (Q3 2025), and $153.1 million (Q2 2025) per Business Quant data.